Literature DB >> 12461006

A fusidic acid-resistant clone of Staphylococcus aureus associated with impetigo bullosa is spreading in Norway.

Yngvar Tveten1, Andrew Jenkins, Bjørn-Erik Kristiansen.   

Abstract

OBJECTIVE: To investigate the possibility that the increased prevalence of fusidic acid-resistant Staphylococcus aureus in Norway is caused by clonal spread.
METHODS: Fusidic acid-resistant and -susceptible clinical isolates of S. aureus from patients with skin infections in the Norwegian county of Telemark and fusidic acid-resistant isolates from other parts of Scandinavia were compared. MICs of fusidic acid for bacterial isolates and pulsed-field gel electrophoresis (PFGE) patterns were investigated. Prevalence data for fusidic acid-resistant S. aureus for the period 1992-2001 were obtained.
RESULTS: The prevalence of fusidic acid resistance in S. aureus increased from 1992 to 2001. Eighty per cent of the resistant isolates investigated shared an identical PFGE pattern. The same pattern was found in fusidic acid-resistant isolates from other parts of Scandinavia. Fusidic acid-resistant S. aureus was typically found in impetigo bullosa-like skin disease in children mostly in the summer months.
CONCLUSIONS: Fusidic acid resistance among S. aureus is increasing in Norway and is predominantly caused by one clone of S. aureus. The clone may spread further to other countries, and dissemination may be facilitated by extensive use of topical fusidic acid.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12461006     DOI: 10.1093/jac/dkf217

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  12 in total

1.  Epidemiology of emerging methicillin-resistant Staphylococcus aureus (MRSA) in Denmark: a nationwide study in a country with low prevalence of MRSA infection.

Authors:  Nuno A Faria; Duarte C Oliveira; Henrik Westh; Dominique L Monnet; Anders R Larsen; Robert Skov; Hermínia de Lencastre
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

2.  Dissemination of community-acquired methicillin-resistant Staphylococcus aureus clones in northern Norway: sequence types 8 and 80 predominate.

Authors:  Anne-Merethe Hanssen; Aina Fossum; Jarle Mikalsen; Dag S Halvorsen; Geir Bukholm; Johanna U Ericson Sollid
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

Review 3.  Fighting antibiotic resistance in Sweden--past, present and future.

Authors:  Johan Struwe
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

4.  Association of recurrent furunculosis with Panton-Valentine leukocidin and the genetic background of Staphylococcus aureus.

Authors:  Helena Masiuk; Katarzyna Kopron; Dorothee Grumann; Christiane Goerke; Julia Kolata; Joanna Jursa-Kulesza; Stefania Giedrys-Kalemba; Barbara M Bröker; Silva Holtfreter
Journal:  J Clin Microbiol       Date:  2010-03-03       Impact factor: 5.948

5.  Staphylococcus aureus carriage among GPs in The Netherlands.

Authors:  Michelle Ia Rijnders; Sita Nys; Christel Driessen; Christian Jpa Hoebe; Rogier M Hopstaken; Guy J Oudhuis; Arno Timmermans; Ellen E Stobberingh
Journal:  Br J Gen Pract       Date:  2010-12       Impact factor: 5.386

6.  A fusidic acid-resistant epidemic strain of Staphylococcus aureus carries the fusB determinant, whereas fusA mutations are prevalent in other resistant isolates.

Authors:  Alexander J O'Neill; Anders R Larsen; Anne S Henriksen; Ian Chopra
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

7.  Activity of Fusidic Acid Tested against Staphylococci Isolated from Patients in U.S. Medical Centers in 2014.

Authors:  David J Farrell; Rodrigo E Mendes; Mariana Castanheira; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

8.  Characterization of the epidemic European fusidic acid-resistant impetigo clone of Staphylococcus aureus.

Authors:  A J O'Neill; A R Larsen; R Skov; A S Henriksen; I Chopra
Journal:  J Clin Microbiol       Date:  2007-03-07       Impact factor: 5.948

9.  The use of typing methods and infection prevention measures to control a bullous impetigo outbreak on a neonatal ward.

Authors:  Maike Koningstein; Leon Groen; Kathelijn Geraats-Peters; Suzanne Lutgens; Ariene Rietveld; Petr Jira; Jan Kluytmans; Sabine C de Greeff; Mirjam Hermans; Peter M Schneeberger
Journal:  Antimicrob Resist Infect Control       Date:  2012-11-20       Impact factor: 4.887

10.  Seasonality of MRSA infections.

Authors:  Leonard A Mermel; Jason T Machan; Stephen Parenteau
Journal:  PLoS One       Date:  2011-03-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.